Ranks distinct AI gain and problem claims from the published record. Scores reward impact, independent source strength, scale, confidence, and recency.
By June 2026, a peer-reviewed paper analyzed how AI and AIGC are being integrated into newsrooms, from data mining to co-creation of news products, increasing efficiency and output volume while prompting questions about human professionalism and editorial control.
A preregistered survey experiment in German-speaking Switzerland with 599 participants tested how audiences perceive news excerpts described as human-written, AI-assisted, or fully AI-generated. Participants first rated quality without knowing the production method, then learned how their excerpts were produced and reported engagement intentions.
Published July 6 2026, this law review article argues that Section 230 and the First Amendment do not categorically immunize digital platforms for harms caused by their own design choices. It proposes a typology separating direct primary harms from design decisions from secondary harms from user content and tertiary harms, focusing on personal-data-driven algorithmic targeting and dark patterns like infinite scrolling.
Researchers analyzed 593 tasks across 126 occupations in the cultural and creative industries using GPT-4 generated synthetic annotations of Australian Skills Classification descriptions. They measured cognitive and behavioural rules and estimated AI autonomy feasibility and efficiency potential to map where human, AI, or hybrid carriers fit.
By July 2026, this scoping review had mapped the literature on AI in OSCEs, screening 421 records and including 22 studies across health professions education. It categorized uses in preparation, station construction, scoring, and delivery, and stratified findings by evidence maturity using FACETS, SAMR, and P4 frameworks.
By July 2026, investigators had tested a multimodal AI model originally validated in prostate biopsy specimens on a tissue microarray of 424 prostatectomy cases, generating scores for 414 patients. At 10 years, recurrence-free survival was 74% and metastasis-free survival 96%, and MMAI scores were associated with both endpoints in univariable models.
By July 10 2026, a dual-center Canadian study reported before-and-after results for PhenoMATRIX, an AI-based software that provides continuous culture sorting and interpretation support for urine cultures on laboratory automation. Both a low-volume tertiary hospital and a high-volume community lab saw earlier availability of interpretable results, with measured TTRR changes of approximately 1.3 hours with PM+ automated release and approximately 5.3 hours with earlier manual review.
By December 2025, researchers conducted a systematic review and meta-analysis of 13 trials (n=684) of five emerging biologics for osteogenesis imperfecta, using GPT-4o to perform parallel title/abstract and full-text screening and to assist risk-of-bias assessment. The AI workflow achieved 97.4% sensitivity at abstract level and 88.9% at full-text, reducing total screening time by over 95% with substantial agreement to humans (kappa 0.778).